Hemp Inc.'s (OTCPINK: HEMP) announced Mar. 25 that it has acquired interest in the alternative energy company, Liberated Energy Inc. (OTC: LIBE), by way of a signed consultant agreement.
Per the agreement, Hemp's wholly-owned subsidiary IHMMCC will provide professional consulting services to help Liberated Energy, Inc. market and distribute their alternative energy products in the Industrial Hemp and medical marijuana industries.
Also Developing Vaporizer Products
On Jan. 28, VaporBrands International, Inc. (OTC Pink: VAPR) announced it has entered into a Letter of Intent to form a joint venture with Marijuana Inc., another wholly-owned subsidiary of Hemp.
Under terms of the proposed joint venture, Marijuana, Inc. will assist VaporBrands with the development and distribution of specialized marijuana vaporizing products to be sold primarily through existing medical marijuana dispensary networks.
In addition, VaporBrands and Marijuana, Inc. have agreed to research, develop and distribute vaporizer products specifically for the use of Hemp Oil in natural medicine. Marijuana, Inc. has also agreed to assist VaporBrands in expanding the retail distribution of its current and future electronic nicotine based cigarette products.
This is yet another move by HEMP through a subsidiary that certainly strengthens its position in the marketplace. It also filled a much needed gap in its vertical offerings. While it's too soon to measure how this will affect HEMP's overall revenue, it is a positive move.
Mar. 25, HEMP's share price closed at 11 cents, unchanged from yesterday's close.
Sign up today for timely and hot stock alerts here, or by cutting and pasting the following link in your Web browser: http://www.pennypickalerts.com
GW Pharmaceuticals Plc's Stock Volume and Value Lose Ground
Meanwhile, GW Pharmaceuticals Plc.'s (OTCPINK: GWPRF) stock volume has been falling steadily Mar. 11 as has its share value.
The London-based pharmaceutical share volume had been surging on the heels of a recent announcement the company made that the Food and Drug Administration (FDA) has granted orphan drug designation for Epidiolex(R). This is GW’s product candidate that contains plant-derived Cannabidiol (CBD) as its active ingredient, for use in treating children with Lennox-Gastaut syndrome (LGS), a rare and severe form of childhood-onset epilepsy.
Despite this, GW Pharmaceuticals lately has been trending downward.
There has been no recent or past negative news, so why this is happening is anybody's guess.
In November 2013, GW announced that the FDA had granted orphan drug designation for Epidiolex in the treatment of Dravet syndrome.
Following the successful follow-on offering completed in January 2014, GW intends to advance a full clinical development program for Epidiolex for the treatment of both LGS and Dravet syndromes. Working with leading pediatric epilepsy specialists in the United States,
GW expects to commence an initial Phase 2 clinical trial for Epidiolex in the second half of 2014. This trial, if successful, is expected to lead to Phase 3 pivotal trial programs in both Dravet syndrome and LGS intended to support New Drug Applications with the FDA.
On Mar. 25, GWPRF’s share price closed at $5.50, up 16 cents from its closing price of $5.34 the previous day.
Medical Marijuana to Develop Joint Venture
In other news, Medical Marijuana Inc. (OTC PINK: MJNA) announced on Mar. 20 that it signed a memorandum of understanding to develop a joint venture with LiveWire Ergogenics, Inc. (OTCQB: LVVV) under the name of HempWire, LLC.
This is the San Diego holding company’s foray into the functional foods market with immediate distribution through LiveWire's extensive chain of existing convenience store retailers, grocery stores, and pharmacy chain stores.
Other than this, the Medical Marijuana hasn’t made any major announcements since Feb 5 when its subsidiary reported that it was expanding the global sales base of its industrial hemp-based cannabidiol (CBD) oil.
Still, Medical Marijuana continues to employ a formidable diversified strategy in order to establish a foothold in this burgeoning industry.
For example, on Jan. 31 Medical Marijuana said that it had entered into an agreement with an unnamed company to sell Medial Marijuana's anti-aging cream through the unnamed company’s in-home sales force.
According to the release, the first purchase order from the home-based business organization will be $1,072,251 in products that will ship before the end of the first quarter.
This positive news came a few days after Medical Marijuana announced its newly-formed subsidiaries would be providing armored transport services for companies in the cannabis industry.
Marijuana Inc.'s subsidiary, Wellness Managed Services, has gained this capability by purchasing a 50% stake in MPS International.
Cannabis Security Issue
In a written statement, MPS International's CEO Mike Roberts outlined some specifics about the new armored marijuana transport service.
"Large amounts of product will be moved from grow to wholesaler, warehouse, testing facilities, bakeries, infusion laboratories and finally to retail locations," Roberts said. "Post transaction, and especially right now with federal regulations prohibiting FDIC insured banks from offering financial services to cannabis industry businesses, large amounts of cash will need to be transported between parties securely as this creates an easy target for predators and competing businesses," he added.
Potentially Lucrative Opportunity
In the release, Roberts went on to outline the potential opportunity that existed for providing armor transportation for currently legal cannabis businesses. He pointed out that there are now about 448 dispensaries in Colorado alone, while in California there are an estimated 2,700 dispensaries, co-operatives, wellness clinics, and taxi delivery services.
"Using an average of one armed security officer working 10 hour shifts, 7 days per week billing at the industry standard of $25/hour armed, 52 weeks per year, annual gross revenue created by just 11 locations is more than $1,000,000 for just static physical security," Roberts explained.
Once the company establishes this footprint, it says it will evaluate other cannabis markets such as those in Canada.
On Mar. 25, MJNA share price closed at 30 cents, down 1 cent from its closing price of the 31 cents the previous day.
Pennypickalerts.com issues momentum alerts on stocks that can provide gains to day traders.
Pennypickalerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.
Pennypickalerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Pennypickalerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Pennypickalerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Pennypickalerts.com believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.pennypickalerts.com